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Abstract
Tuberculosis remains one of the deadliest
infectious diseases in Vietnam. Its occurrence is
exacerbated by erratic treatment, in particular by
taking medication only sporadically or if patients
discontinue the medication in an early stage. Previous
approaches to support treatment adherence focus on
monitoring (e.g., tele-observation) or external
stimulation (e.g., rewards). These approaches,
however, have not yet shown the desired effects. We
assert that this is because current approaches focus on
combatting the outcome, i.e., erratic treatment,
instead of tackling the reasons for treatment noncompliance. Notably, the latter is heavily related to the
stigmatization of TB patients and, especially, selfstigmatization. Using a design science research
approach, this paper proposes a research plan for
developing a gamified information system that aims at
reducing patients self-stigmatization, by providing
features that support TB patients community building
as well as TB patients empowerment.

1. Introduction
Being one of the top ten causes of death globally
as well as the leading cause of death from a single
infectious agent ranking even above HIV, tuberculosis
(TB) remains an urgent public health threat [1,2].
While a timely diagnosis and treatment with first-line
antibiotics for six months can cure most patients and
prevents onward transmission, erratic treatment
adherence leads to the continued spread of the
infection, disease chronicity, and especially the
acquisition of multi-drug resistant forms of TB (MDRTB) [3]. In a recent report, the World Health
Organization (WHO) draws attention to about half a
million new cases of MDR-TB globally in 2018,
whose treatment with second-line antibiotics is
significantly longer (from 9 up to 20 months) and more
expensive (≥ U.S.$ 1,000 per person) than the
treatment of non-resistant forms of the infection [4].
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At the same time, the treatment success rate of MDRTB is only at 56% globally [1].
As MDR-TB provides a severe threat to the
WHO's efforts aiming at containing TB infections,
several studies focus on the circumstance of patients
developing drug-resistant forms of TB. Qualitative
studies suggest that interrupted treatment and missing
drug doses is a significant risk factor for developing
MDR-TB, whereas one crucial determinant of
treatment
non-compliance
is
TB
patients'
stigmatization [5,6].
Stigma involves the exclusion, rejection, blame
or devaluation resulting from experience or reasonable
anticipation of an adverse social judgment [7], thereby
being a social determinant that affects health outside
of the ease with which an individual can access
medical services [6]. Notably, there are several
reported cases where TB stigma harmed treatment
adherence and the regular intake of drug doses. For
instance, TB stigma was the most common motivation
cited by HIV-infected Tanzanian patients who did not
complete isoniazid preventive therapy [8]. Also, TB
stigma is associated with non-compliance among
Pakistani TB patients on direct observatory therapy,
i.e., a specific strategy of the WHO to improve
adherence by requiring health workers, community
volunteers, or family members to observe patients in
being compliant with their prescribed medical
treatment [6,9].
Given the stigmatization of TB patients and the
associatively increased likelihood of developing
MRD-TB through a discontinued use of medication,
researchers aim at supporting treatment adherence
using new information and communication
technologies (ICTs), especially, by developing digital
health services. Digital health services are seen as
especially promising as they provide novel
opportunities to combat TB. Thus us because, as
global connectivity expands and modern ICTs become
more widely available and affordable, digital health
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services are destined to become increasingly present
ans supportive in the daily life of TB patients [2,3].
So far, however, studies investigating the
effectiveness of digital or mobile health services on
patients health and treatment adherence attested only
limited impact. For instance, interactive SMS
reminders [10], as well as direct video observation
used to control drug intake, showed only limited
effectiveness [11,12]. Researchers have shown that
SMS reminders and direct video observation instead
serve as a reminder for patients who have
demonstrated prior good adherence, but that they are
not effective if in the case of patients making an active
effort to avoid therapy, e.g., pretending to swallow.
This paper argues that the reasons for the current
lack of efficiency of digital health services aiming at
fostering TB treatment adherence might be two folded.
First, current health services focus on the outcome and
control aspects of TB treatment adherence rather than
on the causes of treatment non-compliance, which is
frequently observed to be TB stigma as well as
consequential effects, such as social isolation, the loss
of job and working hours, and food insecurity. Second,
by focusing on the outcome instead of the causes of
treatment non-compliance, patients are exposed to
high external pressure, eventually leading to a lower
individual sense of self-efficacy and self-control
[3,13,14].
Therefore, we propose a digital health service that
fosters personal responsibility for one’s own health on
the one side, while helping patients to cope with TB
stigma on the other side. We intend to accomplish this
by assisting patients to build communities among
infected, thereby integrating gamified design elements
that foster personal engagement, a sense of belonging,
and digital interaction in the course of the TB
treatment. Specifically, we focus on the aspect of
community building, since it has already been shown
to be an effective tool against the spread of TB and
HIV/AIDS in Africa, achieved through the
empowerment of patients and the increase of selfresponsibility [6].
Putting these insights together, this paper is
dedicated to describe a comprehensive research plan
to design and develop a gamified TB treatment
adherence system that not only tackles the issue of
treatment non-compliance but also fosters patients'
engagement in TB therapy. Drawing on cognitive
evaluation theory, we argue that the current health
services are rarely sufficient to keep patients
engagement in their long-term treatment plan, as they
are solely exposed to extrinsic motivation (i.e., the use
of controls or reward programs). By designing a
gamified system, however, we focus on fostering
intrinsic motivation, which is consistently more

predictive of human behavior than extrinsic
motivation [15,16].
Although often reduced to joy alone, intrinsic
motivation involves other factors such as the need for
competence (i.e., self-esteem) and autonomy (i.e.,
personal control), whose activation enables patients to
take more responsibility for their health [17]. Aimed
at triggering intrinsic motivation, we implement game
design elements (e.g., collecting badges or reward
points, visualization of achievements, social
discovery, or quests) that foster community building
and exchange between those affected. As a result, we
expect patients to empower themselves and others,
which actively reduces the negative effects of TB
stigmatization.
The remainder of this paper is structured as
follows: The next section briefly describes the
framework that guides our approach in designing a
gamified system for TB treatment adherence. Notably,
we elaborate on the elements of the framework,
including our target system, i.e., a district in Ho-ChiMinh city in Vietnam, which is known to be a highburden MDR-TB country [1]. In the following section,
we propose research steps needed to be conducted to
design a gamified system for TB drug adherence as
outlined above. As we apply design science research,
we further explain and specify the assessment criteria
for the system and eventually provide a conclusion and
outlook.

2. Gamified System Design Framework
Gamification is defined as the incorporation of
game design elements into a target system [18]. While
often confused with full-fledged games, gamification
merely adds a layer to the real world, without
scarifying real-world functionalities. The design of a
gamified system, thus, is imbued with high complexity
since there is the need for taking into account both real
words and game functionalities. Given this
complexity, [18] developed a framework that guides
researchers in their attempt to design gamified
systems, as depicted in Figure 1. Notably, the
framework is divided into four building blocks, which
we describe briefly in the following.

2.1 Gamified System
The first building block is the gamified system,
which, consisting of both gamification objects and
gamification mechanics. Gamification objects thereby
describe the basic building blocks of a gamified
system, including items, characters, or visual assets,
which either serve to create sensory experiences or
provide functionalities. Gamification mechanisms
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refer to the rules that govern the interaction between
the user and the game objects, e.g., rules concerning
how many points users get for a specific activity in a
reward-based game [18]. Notably, several possible
gamification mechanics mainly depend on the target
systems' characteristics, meaning that design elements
need to be congruent with the targeted users, tasks, and
the technology [18].

Gamified principles, as well as all other building
blocks of the gamified system, however, need to be
carefully planned, reviewed constantly, and be
discarded if necessary. This is because gamified
design systems often do not work as intended as
divergent dynamics emerge while in use. Particularly,
this means that there is a paucity of practice-based
wisdom that can guide and promise a successful

Figure
Framework to
to design
design aagamified
system
Figure
2.1.
Framework
gamified
system

development and implementation of our intended

2.2 User-System Interaction
Gamification mechanics plus actions taken by the
user result in user-system interaction, which is the
second building block of the gamified system design
framework. While the importance of user-system
interaction is often underestimated in design science
research approaches (as they are typically solutionoriented) [19], in gamified systems, user-system
interaction is of utmost importance and includes
system-user communication as well as communication
with other users [18]. Eventually, setting up the usersystem communication significantly influences the
quality of the communication, e.g., how feedback is
present to users and determines its overall acceptance
among users.

2.3 Gamification Design Principles
Gamification design principles or higher-level
design principles are formulas or rules for designers.
For instance, design principles can be expressed in
how users onboard to the game, by keeping outcomes
uncertain or providing frequent rewards and
immediate feedback supporting different user styles
[18]. Examples of gamification design principles
include the use of timely feedback, the ability to set
personalized goals and messages as well as social
supports, e.g., to give other users positive
encouragement [18].

gamified system. Consequently, when elaborating on
our intended outcome, i.e., meaningful engagement,
we need to obey that designing for this outcome is
probably hard as it emerges over time and patients'
interest to work and engage within the system [18].

2.4 Meaningful Engagement
Eventually, meaningful engagement represents
the overarching goal of a gamified system. In
particular, [18] describe meaningful engagement to be
consisting of two building blocks, i.e., instrumental
and experimental outcomes. While instrumental
outcomes are purpose orientated, i.e., the increase of
sales or inclines in the total number of users,
experimental outcomes address the psychological state
of a recipient's perception by, for example, creating
positive feelings or emotions that lead to an improved
engagement with the gamified system. Experimental
outcomes should, thereby, not be understood as a mere
additional benefit in the sense of positive side effects,
but as equally important as the instrumental outcomes
[18]. Notably, [18] recommend the identification of
desired experimental outcomes before the gamified
system is designed in order to support the creation of
instrumental outcomes.
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3. Research Plan: Toward Designing a
Gamified System for TB Drug Adherence
We follow a design science research (DSR)
approach [19] to develop and design a gamified drug
adherence system that incorporates and obeys the
building blocks of the above-presented framework
[18]. Thereby, we build upon accumulated design
knowledge in the solution space, i.e., we use the
framework that was built to solve related problems
(i.e., its usage to design gamified systems) and transfer
this knowledge to the contextual problem space of TB
stigmata and its relationship with TB treatment
adherence in urban Vietnam [20].
We strive for a mainly solution-oriented DSR
project by going through the six main phases of the
DSR process, i.e., problem identification and
motivation, definition of objects, design and
development, demonstration, evaluation, and
communication [19,21]. To achieve patients'
engagement in community building and to foster TB
patients' empowerment, we use the described
framework [18], concerned with the design of
gamified systems for guidance, and as a knowledge
base to develop and design the treatment adherence
system.
We start describing our approach by opening up
the problem space and describing the target system in
the following.
Problem space and target system: The DSR
approach, as well as the framework, require – in a first
step – to fully grasp the problem space residing within
the target system. We aim at implementing a gamified
TB adherence system in a district of Ho-Chi-Minh
City, Vietnam, which is known to be profoundly
affected by TB [1]. Vietnam is a middle-income
country in Southeast Asia, with a TB incidence of 182
per 100,000 population in 2018 [1]. While the country
makes ongoing progress in reducing the overall TB
burden by approximately 3% per year over the past ten
years through a range of interventions (e.g., household

contact investigation, TB preventive treatment, new
TB diagnostics, active case finding), the WHO
classifies Vietnam as a high TB and, especially, high
MDR-TB burden country [4]. Tuberculosis control is
centrally administered by the National TB Program
(NTP), and first-line medications are dispensed freeof-charge, mostn commonly once a week by health
workers at district clinics or commune health posts
[22]. Despite the free dispense of antibiotics and
support from various NGOs, TB remains one of the
most severe forms of infectious diseases in Vietnam,
which is, among others, because of the still
predominant stigmatization of TB patients, whereby
stigmatization is a social determinant of health [6]. In
particular, it has been shown that the prevalence of the
TB in Vietnam is even mainly due to social
determinants and indirect costs of the disease,
including, among others, stigmatization, loss of
employment, discrimination, and additional costs due
to extra travel or food supplementary costs [6].
Design objectives: Following the DSR
methodology, we aim to define objectives, i.e., what a
(better) artifact has to accomplish, in a second step
[19]. We, thereby, target each of the building blocks
of the gamified design framework subsequently,
starting with the outcome, i.e., the instrumental and
experimental outcome which comprise meaningful
engagement, as proposed by [18]. Table 1 summarizes
the key guiding research questions, the proposed
approach, as well as the objective for each of the
framework's building blocks. Within the framework of
the design project, we will work through these steps
one after the other and divide them into individual
research projects.
Demonstration: DSR research requires the
demonstration of the artifact, e.g., the prototype
designed. While this is out of the scope for this paper,
it is intended to be addressed in future works after all
the design-specific characteristics of the system have
been specified. Notably, this also holds for the
communication of results, being the final step of the
DSR methodology [19]

Table 1. Framework building blocks and proposed research steps
Framework
Building
Blocks

Key guiding research question

Research Approach

Step 1:
Meaningful
engagement

What is the patients' desired
instrumental and experimental
outcome when using the gamified
system?

• Identification of issues and factors
that prevent the continuous intake of
TB medication using semi-structured
interviews [23]

Step 2:
Gamified
System

What are the concrete game
objects and mechanics that
promote meaningful engagement

• Literature overview of already
applied gamified systems, the
context, and their effectiveness.

Design Objectives
Create a system design that
incorporates functionalities
required by TB patient, which
enhance the feeling of control
and empowerment from a '
patient's view
Identification and
implementation of concrete
design elements that promote
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Step 3:
Gamification
principles

How can we translate the relation
of patients' needs and game
objects/mechanics into higherorder principles, i.e., core
properties of the gamified
system?

Step 4:
User-system
interaction

What are the desired
technological and functional
affordances of the gamified drug
adherence system?
How can we design a gamified
system such that affordances are
immediately perceptible by users?

• Creation of an evaluation matrix that
helps to classify the usefulness of
gamified elements from a 'user's
perspective or rating [24]
• Literature review on gamification
principles (e.g., autonomy, local
interactivity, rules of engagement,
communication) and their
effectiveness [25]
• Mapping of identified mechanism to
the target system and game objects/
mechanics [26]

the instrumental and
experimental outcomes from
the user's perspective

• User observation of patients using a
prototype of the gamified system
[27]
• Adaption of the prototype to design
for affordance actualization [28]

Identification and
actualization of affordances of
the gamified system by
design, i.e., providing general
action possibilities opened up
by the system to the patient.

While there is no prototype readily available now,
we want to use this paper to demonstrate the expected
and intended impacts of the system on the current state
and relationship between the government, NGOs,
public and private healthcare facilities, and patients.
Figure 2 shows these relationships and associated
responsibilities characterizing the state of control of
and care for TB and TB patients in Vietnam.
Following [8] and [13], the current TB control and
care system creates barriers to patients treatment
success and adherence that are, among others, caused
by the distance of patient's houses to clinics they have
to visit in order to receive their treatment as well as the
time and costs for traveling to private or public clinics.

Identification and
actualization of affordances of
the gamified system by
design, i.e., providing general
action possibilities opened up
by the system to the patient.

treatments are present in the current TB control and
care system [29].
While it would be naïve to assume that scholarly
recommendations and proposed interventions aimed at
improving practical aspects and the functioning of the
TB control and care system, are capable of sustainably
changing the TB control and care system, instead, we
propose evoluationary rather than disruptive measures
to improve TB control and care in Vietnam. Notably,
we want to demonstrate how the envisaged gamified
system is likely to be integrated into the existing
system thereby expected to decrease psychosocial
barriers for patients. Figure 3 exemplary depicts the
integration of the gamified system in the current TB
control and care system. With the
introduction of the envisaged gamified
system, we intend to stimulate patients'
engagement. However, we also expect
several cross effects to emerge that enhance
and make the existing TB control and care
system more efficient. Notably, we expect
distinguishing impacts of the gamified system
to unfold on three levels. Thereby, we expect
distinguishing impacts of the gamified system
to
unfold
on
an administrational,
informational, and a personal level.

Figure 2. Current TB control and care

Moreover, patients recorded that they often forgot
or intentionally omitted scheduled appointments due
to expected stigmatization, meaning that both practical
and psychosocial barriers to attend and to adhere to
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Figure 3. Expected impact of the gamified system on TB control and care

First, the envisaged gamified systems is intended
to increase patients' engagement in well as
acountability for patients' own health. Thereby, we
expect an impact on the patients' personal level, which
we define as patients' level of engagement in their TB
treatment, arising from the use of the system for
achieving and mastering game elements and
mechanisms. The gamified systems also enables
patients to compare their achievements with the ones
of others, cheer each other up, as well as to get in touch
with other patients. These features are enabled by the
gamified systems' core functionalities, as summarized
in the figure.
Second, by using the system and engaging in
gamified elements, health care service providers might
receive insights into patients' overall health education,
knowledge on TB and its dissemination. Vice versa,
health care service providers are able to upload
educational health information on the system, as well
as potentially creating gamified challenges on their
own by which means they were able to obtain further
patient-related user data, enabling the analysis and
evaluation of a patients individual health status.
Reminder functions, e.g., for appointments or drug
intake, can be easily integrated into the system through
the health service provider, which positively affects
the administrational level of the TB control and care
system. We define impacts of the administrational
level as the extent of administrational ease that is
achieved by the voluntary completion of playful tasks
by patients and the release of data, which enables
appointment reminders and other automated
functionalities.
Eventually, on an informational level, the
gamified system serves as a centralized database that
captures educational health information, patients'
health status as well as additional information, such as
weight and age, given the prerequisite that patients are
willing to share these informations. We define the

impact on the informational level as the degree of
integration and share-ability of information through
the digital storage of health-related data via the
gamified system.
Evaluation: For the evaluation of the envisaged
gamified TB drug adherence systems, we will assess
the following evaluation criteria, i.e., feasibility,
usability, and acceptability. While we will attach great
importance to the rigor of the research projects in the
concrete development of the prototype, these criteria
are initially aimed to show the applicability of the
gamified system, since the overall success, i.e., the
real-world impact, will be measured by this [30].
Feasibility: Following [31], we define feasibility
in the context of the gamified system as the extent to
which we expect the implementation of the gamified
system to be "easy" and convenient. Notably, we will
account for how "easy" the system is integrable into
the daily health routine of TB patients, as well as
whether the system introduced inconvenience to
patients or governmental or non-profit health care
providers. Furthermore, we will assess whether the
patients' mental load during thesuse of the system is
manageable and whether if staff is needed to train
patients to integrating the app into their daily life and
health care routines [31].
While these factors need to be tested, we expect
mixed outcomes to result from the feasibility test. This
is because Vietnam is among the countries with the
highest rate of mobile phone ownership (131 mobile
phone subscriptions per 100 inhabitants), and
approximately 38,4 million are smartphone users [32].
Consequently, we expect that less effort will have to
be invested into the integration of the system regarding
patients' daily life if we provide mobile accessibility to
the gamified system. At the same time, however,
integration might be tricky if patients refuse to take
their daily medication, either because they do not
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believe in the treatment or try to cover up the infection
[6,33].
Usability: Usability is defined as the extent to
which patients can adequately record and track data
concerning their treatment adherence and whether or
not the functions of the gamified systems enhance
treatment compliance [31]. We, therefore, aim to test
the effectiveness of the system in terms of both
treatment compliance, as well as stigma reduction.
While the first can be easily tracked using the system
data, as well as health data, being easily integrated into
the gamified system by providing interfaces to general
health practitioners or hospitals treating TB patients,
we will assess stigma reduction, using a stigma
assessment scale [34,35]. In particular, we will
develop and test a self-stigma scale to measure stigma
patients suspected to have TB. In particular, we focus
on self-stigmatization as we assume a lower level of
self-stigmatization to be equal with patients'
empowerment. This is because, while it is tough to
change social believes about a disease within the
society [6], our approach strives to changes the
perception of stigmatization by patients through
community-building and empowerment by the means
of the gamified system.
Acceptability: Acceptability of the gamified
systems refers to question whether or not the gamified
system is likable by TB patients, including the
interface and navigation features [31]. To ensure
acceptability, we will conduct several iterations of preprototype- and prototype acceptance testing [36].
Therefore, we are optimistic about designing a
gamified TB treatment adherence system that is useful
and acceptable to TB patients. However, there are
overarching issues that affect usability and, especially,
the acceptability of the gamified system, which require
special investigation and testing.
Overarching considerations: System and,
especially, interface design are driven by cultural
aspect [37]. Thus, we need to take into account that the
initial design of the interface needs to be revised by
several iterations until we reach a good culturetechnology fit. Otherwise, our system runs the risk of
,despite providing suitable features, not being
accepted and, consequently, being effective [38].
Besides cultural aspects, differences in gender are also
prevalent and should be taken into consideration. For
instance, it has been shown that female TB patients
have stronger fears about the consequences of their
illness, including the misbelief that TB medication
leads to sterility [39]. Therefore, we expect more
resistance among female TB patients to test and use
the gamified system, which we need to consider when
designing the TB drug adherence system, e.g., by

offering an incognito mode to test the gamified
system.

4. Conclusion and Outlook
This paper provides initial insights into a
comprehensive research project that aims to introduce
a gamified system to support tuberculosis (TB) drug
adherence by fostering engagement of patients in the
course of their treatment through community-building
and TB patients' empowerment. We propose to
address the problem at the root by empowering TB
patients through community building that is fostered
by game design elements. In this research-in-progress
paper, we focus on the objectives and evaluation
criteria of our solution, which are subject to
identification and investigation by empirical research.
The relevance of this project is evident, when looking
at the ever-present amount of multi-drug resistant
cases of TB in Vietnam, that exist despite the public
accessibility and free provision of TB tests and
antibiotics through the Vietnamese government.
Additionally, numerous non-governmental institutions
advise and support patients with respect to the
continuity of drug intake, thereby offering social care
and health care.
Moreover, while several solutions exist that
already integrate new information and communication
technologies in the treatment surveillance, they do not
show the desired effectiveness. We submit that this is
because they focus on the outcome, i.e., treatment noncompliance, instead of focusing on the reasons for
non-compliance. Among others, TB stigmatization is
one such reason for treatment non-compliance.
The proposed research project and approach to
tackling TB treatment non-compliance in Vietnam, of
course, needs to be viewed in light of the limitations.
Primarily this means that we present a research project
being in a very early stage of its development.
However, given the social and practical relevance, as
well as the theoretical foundation on which this
proposal builds, we are convinced that this paper is of
relevance for practitioners and researchers,
encouraging discussions on the proposed solution, as
well as on the use of gamified systems to address
healthcare issues more generally.
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